Pfizer, Siemens Partner in Companion Diagnostics

Article

Siemens enters agreement with Pfizer to commercialize diagnostic tests for therapeutic products across Pfizer's pipeline.

Siemens has entered into an agreement with Pfizer to design, develop, and commercialize diagnostic tests for therapeutic products across Pfizer's pipeline. Under the agreement, Siemens will be one of Pfizer's collaboration partners to develop and provide in vitro diagnostic tests for use in clinical studies.

The partnership will help Siemens' in providing clinical diagnostic solutions for hospital and reference laboratories, specialty laboratories, and point-of-care settings (including clinics and physician offices) to help enable diagnostics development.

Source: Siemens

Recent Videos
Behind the Headlines episode 6
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Behind the Headlines episode 5
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content